GlassScriptPhysician profile
Paul J Azar
NPI 1245222850
$8,012.68
in general payments reported to CMS, 2019-2025
24 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $711 · 2020: $3,208 · 2021: $2,898 · 2022: $236 · 2023: $653 · 2024: $46.24 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $959.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,021.80 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,266.07 | 2020-2021 | |
| Alcon Vision LLC | $703.32 | 2019-2025 | Lensx, Clareon, Wavelight Ex500 Excimer Laser |
| Abbvie INC. | $326.33 | 2022-2023 | Durysta |
| Allergan, INC. | $214.31 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $176.16 | 2019-2025 | Cequa |
| Glaukos Corporation | $170.96 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $151.07 | 2022-2025 | Tecnis Simplicity, Tecnis Iol, Catalys System |
| Biotissue Holdings INC. | $148.33 | 2021-2025 | |
| Optos, INC. | $138.58 | 2019 | |
| Horizon Therapeutics Plc | $124.99 | 2021 | |
| Mallinckrodt Hospital Products INC. | $97.99 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $60.84 | 2021 | |
| Genentech USA, INC. | $57.57 | 2019-2021 | |
| Shire North American Group INC | $56.98 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $53.49 | 2023-2025 | Tyrvaya, Ryzumvi |
| Lkc Technologies, INC. | $52.73 | 2023 | |
| Aerie Pharmaceuticals, INC. | $36.06 | 2020 | |
| Paratek Pharmaceuticals, INC. | $32.13 | 2022-2023 | Nuzyra |
| Eyevance Pharmaceuticals LLC | $30.10 | 2021-2022 | |
| Senseonics, Incorporated | $27.00 | 2019 | |
| Kala Pharmaceuticals, INC. | $24.98 | 2021 | |
| Ivantis, INC | $24.64 | 2020 | |
| Merck Sharp & Dohme LLC | $16.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Azar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.